Tomisaki I, Harada M, Sakano S, Terado M, et al. Differential impact of proton pump inhibitor on survival outcomes of patients with advanced urothelial carcinoma treated with chemotherapy versus pembrolizumab. Int J Urol 2023;30:738-745.
PMID: 36693764